Over the past couple decades, folic acid has been largely heralded as a wonder vitamin. In the 1980s, studies began to show that folic acid might help prevent some cancers. Taking the vitamin has also been linked to reduced birth defects. In fact, since cereals and grains fortified with folic acid began hitting the market […]
Too Much Folic Acid May Cause Cancer Read More »
A recent study from Oregon Health and Science University (OHSU) indicates that 40 percent of all cancer trials do not achieve the minimum accrual goals necessary to achieve a statistically significant conclusion. Additionally, it was found that the longer the preparation time required to develop the clinical trial, the harder it was to accrue enough
Long Development Times Linked to Low Patient Accrual Rates for Cancer Trials Read More »
At present, cancers are by and large treated based what part of the body the tumor has infected. To put it another way, breast cancer patients, colon cancer patients and lung cancer patients all undergo different treatment methods.However, this type of categorization seems to be on the shift. While location of the cancer tumor will
Oncologists Take Cancer Treatment Personal Read More »
Overall, men are 40 percent more likely to die from cancer, according to a recent study. Additionally, men are 16 percent more likely to contract cancer in the first place. The study, which was initiated by Cancer Research UK, suggests alarmingly different expectations of cancer survival between men and women.When looking specifically at cancers that
Men Estimated to be 40 Percent More Likely to Die From Cancer Read More »
Malignant gliomas are an especially difficult type of cancer to treat. Manifesting in the brain or spine, patients diagnosed with this deadly form of cancer have only a 3 percent likelihood of surviving five years or more. Now, a new method for delivering chemotherapy drugs is showing early signs of prolonging survival times among patients
Direct Chemo Delivery Shows Signs of Prolonging Patient Survival Read More »
A spokesperson for Eli Lilly and Co. (LLY), one of the leading US pharmaceutical manufacturers, released a statement last week that the US Food and Drug Administration (FDA) has granted a fourth approval for the cancer drug ALIMTA to be used as an upkeep therapy for locally advanced or metastatic non-small cell lung cancer (NSCLC).
Headline: Lilly Gets Fourth FDA Approval for ALIMTA Read More »
Idiopathic pulmonary fibrosis (IPF) is a rare lung disease with an expected survival time of about three to five years. Now, the link between a specific protein in the lungs and the progression of the illness may help doctors make better decisions about treatment methods for each individual patient. The name of the protein is
Protein Helps Indicate Progression of Rare Lung Disease Read More »
Pain is an infamously difficult cancer symptom to treat. Even when potent pain relievers are used, waves of pain often flare up and break through the effects of the medication. This type of pain is known as breakthrough pain. Now, doctors and patients have a new tool to help combat breakthrough pain. Recently, the U.S.
Opioid Pain Reliever Approved for Breakthrough Pain in Cancer Patients Read More »
Cancer cells incorporate a number of mutated genes to wreak havoc on our healthy human bodies. However, findings from a recent study now indicate that cancer cells also rely heavily on the presence of non-mutated genes for survival. Researchers at Harvard Medical School and Brigham and Women’s Hospital carried out the study. The researchers made
Cancer Cells Rely on Healthy Genes for Survival Read More »
During chemotherapy, it is not uncommon for a tumor to become resistant to treatment over time. This fact has proven to be a major obstacle in cancer treatment and, with few alternatives for treatment, patients with chemo-resistant cancer often experience limited timeframes for survival. In an effort to reduce a cancer’s ability to resist chemotherapy
“Trojan Horse” Proves Effective in Lowering Cancer’s Resistance to Chemotherapy Read More »